185 related articles for article (PubMed ID: 9717916)
1. Implantable cardioverter defibrillators--for whom?
Connolly SJ
Lancet; 1998 Aug; 352(9125):338-40. PubMed ID: 9717916
[No Abstract] [Full Text] [Related]
2. Implantable cardioverter defibrillators in the United States: understanding the benefits and limitations of implantable cardioverter defibrillator therapy based on clinical trial results.
Gottlieb C; Callans DJ; Marchlinski F
Pacing Clin Electrophysiol; 1998 Nov; 21(11 Pt 1):2016-20. PubMed ID: 9826851
[No Abstract] [Full Text] [Related]
3. Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS).
Bokhari F; Newman D; Greene M; Korley V; Mangat I; Dorian P
Circulation; 2004 Jul; 110(2):112-6. PubMed ID: 15238454
[TBL] [Abstract][Full Text] [Related]
4. Clinical trials of implantable defibrillators.
Myerburg RJ; Castellanos A
N Engl J Med; 1997 Nov; 337(22):1621-3. PubMed ID: 9371860
[No Abstract] [Full Text] [Related]
5. [Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone].
Della Bella P
Ital Heart J Suppl; 2000 Aug; 1(8):1070-1. PubMed ID: 10993020
[No Abstract] [Full Text] [Related]
6. Randomized clinical trials: how long should they last?
Wellens HJ
Circulation; 2004 Jul; 110(2):107-8. PubMed ID: 15249514
[No Abstract] [Full Text] [Related]
7. Drugs versus devices in controlling ventricular tachycardia, ventricular fibrillation, and recurrent cardiac arrest.
Haverkamp W; Eckardt L; Borggrefe M; Breithardt G
Am J Cardiol; 1997 Oct; 80(8A):67G-73G. PubMed ID: 9354413
[TBL] [Abstract][Full Text] [Related]
8. Food for afterthought: reflections from 2 implantable cardioverter defibrillator trials.
Rahimtoola SH
Arch Intern Med; 2004 Sep; 164(17):1835-9. PubMed ID: 15451756
[No Abstract] [Full Text] [Related]
9. Are implantable cardioverter-defibrillators better than conventional antiarrhythmic drugs for survivors of cardiac arrest?
Zipes DP
Circulation; 1995 Apr; 91(8):2115-7. PubMed ID: 7697837
[No Abstract] [Full Text] [Related]
10. Amiodarone versus implantable cardioverter defibrillator for asymptomatic nonsustained ventricular tachycardia in nonischemic dilated cardiomyopathy.
Cawley PJ; Al-Khatib SM
Am Heart J; 2004 May; 147(5):790-1. PubMed ID: 15131532
[No Abstract] [Full Text] [Related]
11. Current management of ventricular arrhythmias.
Anderson MH
Br J Hosp Med; 1994 Sep 7-20; 52(5):204-9. PubMed ID: 7529627
[TBL] [Abstract][Full Text] [Related]
12. Effect of risk stratification on cost-effectiveness of the implantable cardioverter defibrillator.
Owens DK; Sanders GD; Heidenreich PA; McDonald KM; Hlatky MA
Am Heart J; 2002 Sep; 144(3):440-8. PubMed ID: 12228780
[TBL] [Abstract][Full Text] [Related]
13. Chapter 10. Current evidence on the cost effectiveness of the implantable cardioverter defibrillator.
O'Brien BJ; Yee R
Can J Cardiol; 2000 Jun; 16 Suppl C():45C-7C. PubMed ID: 10887279
[No Abstract] [Full Text] [Related]
14. Proarrhythmias and antiarrhythmias: two sides of the same coin.
Kowey PR; Yan GX
Heart Rhythm; 2005 Sep; 2(9):957-9. PubMed ID: 16171750
[No Abstract] [Full Text] [Related]
15. A comparison of long-standing implantable cardioverter-defibrillator patients with and without appropriate therapy for ventricular arrhythmias: impact of a widening QRS.
Dizon J; Chen K; Dizon S; Biviano A; Whang W; Ehlert F; Vazquez J; Nazif T; Garan H
Europace; 2011 Jan; 13(1):77-81. PubMed ID: 21149513
[TBL] [Abstract][Full Text] [Related]
16. The role of amiodarone in the management of patients with cardiac arrest.
Franks AM; Watterson KS
J Ark Med Soc; 2000 Dec; 97(6):196-9. PubMed ID: 12876823
[No Abstract] [Full Text] [Related]
17. [Pharmacologic therapy of ventricular tachyarrhythmias: value of class III anti-arrhythmia drugs].
Haverkamp W; Borggrefe M; Block M; Böcker D; Breithardt G
Z Kardiol; 1996; 85 Suppl 6():97-106. PubMed ID: 9064989
[TBL] [Abstract][Full Text] [Related]
18. [The amiodarone-beta blockers combination could represent an alternative treatment in patients at risk for sudden death in which a benefit from implantable defibrillators has not been clearly demonstrated].
Alboni P
Ital Heart J Suppl; 2002 Mar; 3(3):337-43. PubMed ID: 12040849
[TBL] [Abstract][Full Text] [Related]
19. Application of the main implantable cardioverter-defibrillator trials and the 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.
Proclemer A; Ghidina M
J Cardiovasc Med (Hagerstown); 2007 May; 8(5):320-3. PubMed ID: 17443096
[No Abstract] [Full Text] [Related]
20. Cost-effectiveness of the implantable cardioverter defibrillator?
Hlatky MA; Bigger T
Lancet; 2001 Jun; 357(9271):1817-8. PubMed ID: 11410185
[No Abstract] [Full Text] [Related]
[Next] [New Search]
